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Abstract – Coliform mastitis is one of the most difficult diseases to treat in the modern dairy industry.
Curative therapy with antibiotics remains only moderately effective and depends on the stage at
which the disease is treated. The most successful strategies for combating coliform mastitis appear to
be prevention by hygienic management or prophylactic immunization. The severity of clinical symp-
toms of coliform mastitis has been shown to be reduced by immunization with the Escherichia coli J5
vaccine. However, although the J5 vaccine has been licensed in the United States for about 10 years,
the immunological basis of its mechanism of action is still unknown. Until now, protection by J5 vac-
cination has often been explained by a straightforward mechanism of enhanced antibody production
resulting in increased opsonization of coliform bacteria and lipopolysaccharides (LPS). The possibil-
ity that J5 vaccination could decrease risk factors for coliform mastitis such as impaired blood
polymorphonuclear neutrophil leukocyte (PMN) diapedesis has never been investigated. This review
provides arguments to support the hypothesis that J5 vaccination may reduce the severity of coliform
mastitis by inducing a condition of mammary gland hyper-responsiveness, characterized by a
T helper 1 (Th1) response and mediated by memory cells inside the mammary gland, finally resulting
in enhanced PMN diapedesis upon an intramammary infection.
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Résumé – Mécanismes d’action possibles du vaccin J5 dans la protection contre la mammite
coliforme sévère de la vache laitière. La mammite coliforme est une des maladies les plus diffici-
les à traiter dans l’industrie laitière moderne. La thérapie curative avec des antibiotiques reste peu ef-
ficace, dépendant du stade de la maladie. Les stratégies les plus efficaces pour combattre la mammite
semblent être la prévention par des mesures d’hygiène ou la prophylaxie vaccinale. La sévérité des
symptômes cliniques de la mammite coliforme peut être réduite par immunisation avec le vaccin
Escherichia coli J5. Cependant, alors que le vaccin J5 a été mis sur le marché aux États-Unis depuis
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environ 10 ans, les bases immunologiques de son mécanisme d’action ne sont pas connues. Jusqu’à
présent, la protection par le vaccin J5 a souvent été attribuée à un simple mécanisme de stimulation de
la production d’anticorps résultant en une augmentation de l’opsonization des bactéries coliformes et
des lipopolysaccharides (LPS). La possibilité que la vaccination avec J5 pourrait diminuer les fac-
teurs de risque de la mammite coliforme, tels qu’une diapédèse insuffisante des leucocytes neutrophi-
les polymorphonucléaires (PMN) sanguins, n’a jamais été étudiée. Cet article de synthèse cite des
arguments supportant l’hypothèse que la vaccination avec J5 pourrait réduire la sévérité de la mam-
mite coliforme en induisant une hyper-sensibilité de la glande mammaire. Celle-ci serait caractérisée
par une réponse immunitaire de type “T helper 1” par l’entremise de cellules mémoire de la glande
mammaire, résultant finalement dans une augmentation de la diapédèse de PMN suivant une infec-
tion intramammaire.
vache laitière / mammite coliforme / vaccin J5 / cellule T / réponse immunitaire
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1. INTRODUCTION
The incidence of severe bovine mastitis
caused by environmental bacteria such as
Escherichia coli is quite high during the
early postpartum period. A great individual
variability between cows in biological re-
sponses to intramammary infections is ob-
served during this period. In fact, all
degrees of severity from peracute to
subclinical are possible [54]. The suscepti-
bility of individual cows to severe coliform
mastitis appears to be associated with the
degree of neutropenia or impairment of
blood polymorphonuclear neutrophil leu-
kocyte (PMN) function. The most impor-
tant risk factors for severe E. coli mastitis
are slow migration of blood PMN into the
mammary gland [14, 23, 55] and their im-
paired oxidative burst activity [1, 6, 13].
Lymphocyte function such as proliferation
and antibody response has also been found
to be impaired during early lactation [30],
but a relation with the severity of coliform
mastitis has not been clearly established.
The Escherichia coli J5 vaccine has
been successfully used in the protection
against severe coliform mastitis [10, 21].
Escherichia coli J5 is a rough (Rc) mutant
E. coli strain. Upon J5 vaccination, anti-
bodies are therefore generated against the
core antigen, which consists of lipid A and
some common core polysaccharides
(2-keto-3-deoxyoctonate, heptose and glu-
cose residues) (Fig. 1) [4, 53]. The presence
of core antigen compounds only, which – in
contrast with O antigens – are highly con-
served among Gram negative bacteria,
forms the basis of cross-protection against a
wide range of Gram negative bacteria. At
first sight, protection afforded by J5 vacci-
nation appears to be related to increased
specific antibody production against LPS
core antigens and enhanced opsonization of
bacteria. However, although serum and
milk antibody titers are increased as a result
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Figure 1. Lipopolysaccharide (LPS) structure of smooth and rough Gram negative bacteria. The LPS
structure of smooth bacteria consists of a polysaccharide side chain (O antigen), R-core polysaccha-
rides and lipid A. The LPS structure of Escherichia coli J5 (a rough Rc mutant) lacks the O antigen
and consists only of lipid A and some common core polysaccharides (2-keto-3-deoxyoctonate,
2 heptose and 1 glucose residues). Together, this LPS structure is called the “core antigen”. Abe,
abequose; Man, mannose; Rha, Rhamnose; Gal, galactose; GlcNAc, N-acetylglucosamine; Glc, glu-
cose; Hep, Heptose; KDO, 2-keto-3-deoxyoctonate (after [53]).
of vaccination [18, 19], a proportionally de-
creased incidence and severity of E. coli
mastitis has not always been readily appar-
ent [15, 21]. There is practically no infor-
mation available about the effects of J5
vaccination on risk factors for severe
coliform mastitis such as decreased PMN
number and function. From the important
role of PMN in the pathogenesis of
coliform mastitis as described above, it can
be proposed that the mechanism of action
of J5 vaccination should be based on the
re-establishment or compensation for re-
duced PMN functions in order to reduce se-
verity during coliform mastitis.
2. POTENTIAL MECHANISMS
OF ACTION OF THE J5 VACCINE
Mastitis research has been concentrated
on the role of PMN as a defense mechanism
by itself; less attention has been paid on the
characterization of lymphocyte-mediated
mechanisms activating these cells. Several
recent studies [29, 44] suggest that lympho-
cytes could also play an important role, but
their precise function in the pathogenesis of
coliform mastitis remains unclear. Two ma-
jor pathways for a role of lymphocytes in
the mechanism of action of J5 vaccination
are explored: (1) modulation of the T cell
mediated immune response; and (2) opso-
nizing or neutralizing effects of enhanced
serum and/or milk antibody titers.
2.1. General schedule of events during
J5 vaccination
The events that will theoretically occur
during J5 vaccination can be derived from
human and mouse models (Fig. 2) (re-
viewed by Guidry and O’Brien [12]). Upon
subcutaneous vaccination, the vaccine first
binds to resident antigen-presenting cells
(APC) which can be macrophages, acti-
vated B cells or dendritic cells. After anti-
gen processing, the resulting products are
expressed on the membrane surface in con-
junction with major histocompatibility
class II (MHCII) molecules. Antigen-pre-
senting cells migrate to lymphoid tissues,
where they bind to CD4+ T cells (T helper
cells, Th). Both CD4+ and CD8+ (cytotoxic,
Tc or suppressor T cells, Ts) belong to the
class of αβT cells. These cells can develop
memory, resulting in a faster and more pro-
nounced response after a 2nd or 3rd con-
tact. Milk lymphocytes of healthy cows
indeed display the phenotype of mem-
ory/activated cells [39, 48].
2.2. Hypothesis 1: J5 vaccination could
polarize the inflammatory response
during coliform mastitis
2.2.1. General characteristics of T helper
type 1 and 2 responses
Upon binding of APC with CD4+ T
cells, the immune response can be classi-
fied as a Th1 or Th2 response. Th1 responses
are characterized by activation of macro-
phages and PMN adhesion, diapedesis and
opsonization. Typical Th1 cytokines are
interleukin-2 (IL-2, growth and prolifera-
tion of Th1 lymphocytes), IL-8 (stimula-
tion of PMN chemotaxis and induction of
endothelial binding sites on PMN), IL-12
(induction of interferon (IFN) production),
IFN-β (stimulation of leukocyte adhesion)
and IFN-γ (stimulation of cytotoxicity and
inhibition of antibody production). A typi-
cal Th2 response consists of B cell activa-
tion to proliferate and differentiate into
antibody-producing plasma cells. Th2
cytokines are IL-4 (stimulation of matura-
tion and Ig class switching), IL-5 (stimula-
tion of B cell proliferation and differen-
tiation) and IL-10 (inhibition of cell- medi-
ated immunity) (reviewed by Guidry and
O’Brien [12]). From these data it can be
proposed that a Th1 response would be ben-
eficial in the outcome of E. coli mastitis, be-
cause of its stimulatory effects on PMN
diapedesis.
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2.2.2. T helper type 1 immune response
and delayed type hypersensitivity
A typical moderate response during
coliform mastitis is consistent with the char-
acteristics of a Th1 type response: enhanced
PMN migration, diapedesis and activation
(Fig. 2). This hypothesis is supported by the
positive effects of IFN-γ treatment on the
outcome of E. coli mastitis [47]. Delayed
type hypersensitivity (DTH) reactions are
also part of the Th1 response and may be
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Figure 2. Potential mechanism of action of the J5 vaccine in reducing severity of coliform mastitis in
dairy cows. Escherichia coli J5 first binds to antigen-presenting cells (APC) which can be
macrophages, activated B cells or dendritic cells (DC). After antigen processing, the product is ex-
pressed on the membrane surface in conjunction with major histocompatibility class II (MHCII)
molecules. APC migrate to lymphoid tissues, where they bind to CD4+ T cells (T helper cells, Th).
Both CD4+ T cells and DC can develop memory, so that the response upon intramammary coliform
infections in J5-vaccinated cows will be faster and more pronounced than in non-vaccinated cows.
CD4+ T cells and DC can migrate towards the mammary gland. During coliform mastitis, APC bind-
ing with CD4+ T cells can result in a Th1 or Th2 response. Th1 responses are characterized by activa-
tion of macrophages and PMN adhesion, diapedesis and opsonization whereas a typical Th2
response consists of B cell proliferation and differentiation. From these data it is hypothesized that a
Th1 response is preferentially mounted in J5-vaccinated cows, because this would benefit the out-
come of E. coli mastitis. This could be mediated by memory CD4+ T cells and/or DC1 cells within the
mammary gland. The inability to mount a Th1 response in severely diseased cows during coliform
mastitis could be tentatively attributed to pregnancy and/or ageing.
induced by J5 vaccination. Preliminary evi-
dence for the existence of DTH reactions in
the bovine mammary gland comes from an
experiment in which enhanced PMN
diapedesis into the mammary gland was in-
duced after intramammary ovalbumin (OA)
injection in subcutaneously OA vaccinated
cows [5]. These results suggested that an
antigen-specific pathway could be elicited
in the mammary gland upon subcutaneous
immunization with that specific antigen.
This could also be the case during J5 vacci-
nation, because PMN infiltration into the
mammary gland has been enhanced in vac-
cinated cows [19]. Similar findings have re-
cently been obtained with Staphylococcus
aureus α–toxin immunized cows [39].
2.2.3. Cell- or antibody-mediated types
of hypersensitivity reactions?
The etiology of hypersensitivity is com-
plex: even in human medicine hypersensi-
tivity reactions are difficult to classify as
antibody- or cell-mediated. Because the ef-
fects seen in subcutaneously OA-vacci-
nated cows could not be mimicked by
intramammary infusion of antigen-anti-
body complexes [5], it seems likely that
possible hypersensitivity reactions during
J5 vaccination are cell- and not anti-
body-mediated. This hypothesis is sup-
ported by the observation that treatment of
mice [11] and neonatal calves [31] with J5
antiserum did not protect them against
shock during intravenous LPS injection.
These observations support the hypothesis
of a cell-mediated pathway during J5 vacci-
nation, rather than passive protection
through increased serum or milk antibody
titers.
2.2.4. Underlying mechanism of failure
to mount a Th1 response
2.2.4.1. Lymphocyte phenotypes during
the early postpartum period
Failure of the immune response in
dairy cows during coliform mastitis could
be associated with changes in the pheno-
type of blood mononuclear cells during the
periparturient period. A dramatic decrease
of some blood T cell subsets were observed
shortly after parturition, whereas B cells
were unchanged [24]. During early lacta-
tion, a decreased CD4+ to CD8+ milk lym-
phocyte ratio was found [33]. Kimura et al.
[22] reported a significant decrease of
blood CD3+, CD4+ and γδ T cells at parturi-
tion. Decreased amounts of Th cells have
indeed been used as indicators for an im-
paired immune function.
2.2.4.2. Role of pregnancy and ageing
in the polarization
of the immune response
Pregnancy has been proposed to cause
the maternal immune system to preferen-
tially mount a Th2 response [58] (Fig. 2).
As a Th1 response may result in fetal ab-
sorption, the Th1 cytokines are generally
harmful to the maintenance of pregnancy.
Bovine blood CD4+ lymphocytes have in-
deed been shown to function primarily as
Th2 effector cells during the postpartum
period [44]. It appears that Th2 cytokines
are predominantly produced by cells from
the feto-placental unit in humans. Vaccina-
tion with paternal lymphocytes results in a
shift towards a Th2 response and is associ-
ated with successful pregnancy in patients
with recurrent spontaneous abortions [42].
In dairy cows, modulation of PMN function
by placenta-derived glycoproteins has been
found [7, 16], but their role in immune
modulation during coliform mastitis is not
completely understood. The phenomenon
that pregnancy can modulate the immune
response towards Th2 could therefore ex-
plain the decreased capacity to mount an
adequate Th1 response during coliform
mastitis in early postpartum dairy cows.
Malfunction of the immune system in the
elderly also appears to be associated with a
Th1 to Th2 cytokine production shift [9].
Increased susceptibility to severe coliform
mastitis has also been observed in older
cows [55] (Fig. 2). Together, these findings
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suggest that impairment of the immune
system in periparturient and in older cows
could also be associated with a shift in
cytokine synthesis during coliform masti-
tis.
2.2.5. Role of memory cells
in the mammary gland
The inflammatory response upon intra-
mammary challenge could be accelerated if
memory cells were present inside the mam-
mary gland. These memory or activated
cells could be T lymphocytes or dendritic
cells that have specifically migrated (hom-
ing) from local subcutaneous lymph nodes
at the site of J5 vaccination towards the
mammary gland (Fig. 2).
2.2.5.1. Homing of memory T cells
towards the mammary gland
The homing phenomenon in general and
to the mammary gland in particular is
poorly characterized in dairy cows. A hypo-
thetical pathway can be derived from hu-
man, rat or sheep models. Migration of
memory T cells occurs preferably through
non-lymphoid tissues whereas naïve T cells
migrate to lymph nodes. The presence of
lymphocytes in tissues is part of mucosal
immunity. These tissues are called “mucosa
associated lymphoid tissues (MALT)”.
MALT is structurally characterized by fol-
licle-associated lymphoepithelium and the
presence of secondary follicles [3]. It can
also be immunohistochemically identified
by the presence of migrating activated lym-
phocytes and IgA producing plasma cells
[2]. Typical MALT are the gut, lungs, nose
(rodents), mesenteric lymph nodes, skin
and subcutaneous lymph nodes (sheep) and
the mammary gland (pigs). In cows, the
presence of MALT has been described in
the intestine [34] and in tonsils [36].
Histological evidence for MALT inside the
bovine mammary gland tissue is not avail-
able, but plasma cells have been demonstrated
in mammary gland mucosa, with increas-
ing concentrations from milk-secreting
parenchyma to the distal teat end mucosa
[32]. The local production of IgA, IgM and
IgG2 in mammary tissue has also been
demonstrated [35].
Homing of lymphocytes is controlled by
the expression of homing receptors on lym-
phocytes and vascular addressins in the
venules of the lamina propria of the gut and
of the lactating mammary gland [59]. Tis-
sue-specific T cell migration is predomi-
nantly a characteristic of αβT cells (CD4+
and CD8+ cells), whereas γδ T cells migrate
randomly [57]. More recent studies in
sheep have shown that tissue-specific mi-
gration is restricted to CD4+ memory cells
[28]. The number of lymphocytes in the
porcine mammary gland increases from
day 80 of pregnancy until parturition, under
the influence of increased prolactin recep-
tor density [40]. This suggests that homing
towards the mammary gland may also oc-
cur through hormonal alterations in dairy
cows. Actual data on bovine lymphocyte
homing are, however, scarce. Milk lympho-
cytes display the phenotype of memory
cells [39, 48]. The percentage of memory
cells in milk was up-regulated following
subcutaneous S. aureus α-toxin immuniza-
tion [39]. Although these authors used a dif-
ferent model than J5 vaccination, their
findings support the general concept that
memory T cells can specifically migrate to-
wards the mammary gland in immunized
cows.
2.2.5.2. Milk lymphocyte phenotypes
during mastitis
During S. aureus α–toxin induced masti-
tis, CD8+ cells were recruited into milk ear-
lier than CD4+ cells: 12 h and 96 h after
challenge, respectively [39]. This suggests
an important role of CD8+ cells as effector
cells in intramammary defense of immu-
nized cows. In field cases, the CD4+ to
CD8+ ratio of milk cells was increased dur-
ing staphylococcal mastitis whereas it re-
mained constant during streptococcal
mastitis [46]. From these data it is clear that
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changes in proliferation and trafficking of
CD4+ and CD8+ are dependent on the anti-
genic stimulus and that lymphocytes proba-
bly play a crucial role in regulating the
inflammatory response of the bovine mam-
mary gland. The effect of J5 vaccination on
the phenotype of milk lymphocytes in
healthy cows and their response upon
intramammary infections with coliform




The APC requirements for differentia-
tion of naïve CD4+ cells into Th1 cells in
J5-vaccinated cows are presently unknown.
Both macrophages and dendritic cells but
not B cells were found to play a role in the
induction of Th1 development in mice [27].
Findings in humans also suggest that
monocyte-derived dendritic cells (DC) play
an important role in the generation of a po-
larized immune response. Committed DC
are currently used for vaccination in cancer
patients in order to induce a Th1-dominant
immune response and stimulate a DTH re-
action, which is required for the induction
of tumor regression [38]. Optimal activa-
tion of T lymphocytes indeed depends on T
cell receptor interaction with peptide/MHC
complexes in conjunction with co-
stimulatory signals, delivered by APC.
Dendritic cells are widely distributed in tis-
sues and play a major role in the induction
of primary T cell dependent immune re-
sponses [37]. The Th1/Th2 commitment of
T cells appears to occur within clusters of
DC and T cells in T cell areas of lymphoid
tissues where DC1 induce the differentia-
tion of Th1 cells and DC2 induce Th2 cells.
This commitment is controlled by typical
Th1 and Th2 cytokines, respectively [43].
The role of DC in the pathogenesis of
coliform mastitis and in the modulation of
the immune response in J5-vaccinated
cows currently remains unknown.
2.3. Hypothesis 2: J5 vaccination
protects against severe coliform
mastitis through increased serum
and milk antibody titers
2.3.1. Effect of J5 vaccination on serum
and milk antibody titers
The classical hypothesis for a mecha-
nism of action of J5 vaccination consists in
the protection by enhanced opsonization of
LPS and bacteria by increased serum and
milk antibody titers. Immunization with the
J5 vaccine indeed increases antibody titers
to E. coli J5 core antigens in serum and
mammary secretions [50]. In a field study,
high serum IgG1 titers against E. coli
O111: B4 (J5) were associated with a de-
creased incidence of clinical coliform mas-
titis [51]. In addition, serum from J5
vaccinated cows showed enhanced in vitro
opsonic activity for E. coli [17]. Thus, it can
be hypothesized that J5 vaccination may
protect against severe coliform mastitis by
stimulation of specific antibody production
against the common core antigen of
Gram-negative bacteria, resulting in en-
hanced opsonization of bacteria and LPS.
However, although increased serum and
milk specific antibody titers are generally
observed following J5 vaccination, a rela-
tion with the incidence or severity of masti-
tis has not always been established [15, 50].
Further evidence to reject the hypothesis
that increased antibody titers provide pro-
tection in J5-vaccinated cows, comes from
the conclusion of Hill [14] that opsonins are
not a limiting factor in the pathogenesis of
coliform mastitis. A fast PMN diapedesis
and the availability of a high number of ac-
tive PMN inside the infected mammary
gland are much more critical for the out-
come of severe coliform mastitis [14, 23,
54, 55].
2.3.2. Effect of lactation stage on
antibody response
Variability in antibody response to J5 im-
munization could be the result of variable
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immunosuppression in early lactation dairy
cows. For example, serum IgG2 titers rec-
ognizing E. coli J5 common core antigen
following vaccination showed a coefficient
of variation of 64% [15]. Serum antibody
titers in J5 vaccinated cows are generally
higher than in control cows, but significant
effects of lactation stage on milk and serum
IgG and IgM titers have been observed in
both control and J5 vaccinated cows [18,
21, 45, 49]. Furthermore, periparturient
cows can be phenotypically classified as
low or high responders to immunization,
based on the magnitude and kinetics of the
antibody response to E. coli J5 or oval-
bumin injection [29, 56]. Whereas about
one third of the cows responded normally,
two third showed a variable degree of
hyporesponsiveness to peripartum immu-
nization [29, 56]. These findings suggest
that the immune deficiency which makes
cows susceptible to E. coli mastitis may
therefore also impair antibody response to
active immunization during early lactation.
2.3.3. Effect of adjuvant
and administration route
on antibody response
The antibody response to J5 immuniza-
tion appears to be dependent on the
adjuvant and the route of administration. In
vaccinated neonatal calves, a significant in-
crease in antibody titers was only observed
with Freund incomplete adjuvant [52]. The
route of immunization also appears to play
a role in the antibody response. A vaccina-
tion schedule that included intramammary
immunization between 2 subcutaneous im-
munizations resulted in higher serum anti-
body titers than the conventional vaccination
schedule with 3 subcutaneous immuniza-
tions [20]. The enhancement of IgG and IgM
titer responses in milk and serum by
intramammary immunization has been ex-
plained by the possibility that cells stimu-
lated locally in the mammary gland may
travel to local lymphatic tissues, thereby in-
creasing systemic antibody response [49].
2.4. Influence of prior exposure
to coliform pathogens
and the effect on J5 vaccination
It is unlikely that naturally occurring
intramammary infections with coliform
pathogens could confer immunological
memory such as with subcutaneous E. coli
J5 vaccination. Firstly, the variability in ge-
notypes among wild-type coliform mastitis
pathogens is very high [26, 41]. This would
highly limit the formation of cross-reactive
antibodies or memory cells. Secondly,
plasma antibody titers were not increased
after intramammary E. coli infections in
both control and J5-vaccinated cows [21].
This suggests that the intramammary route
of immunization does not result in the for-
mation of memory cells, in contrast with
subcutaneous vaccination. Similar results
are, however, obtained with J5 vaccination
into the supramammary lymph node and
subcutaneously in the neck [49]. This sug-
gests an important role for interaction be-
tween antigen and immune cells within
lymphoid tissues in the formation of immu-
nological memory. During naturally occur-
ring intramammary infections with coli-
forms, however, the antigen will probably
never reach the supramammary lymph
node because the attachment of coliform
bacteria to mammary epithelium, which
would be a first necessary step, has never
been observed [8, 25]. Thirdly, older cows –
which normally underwent more intra-
mammary infections – are more susceptible
to severe coliform mastitis [55]. Age or
prior exposure to pathogens also did not in-
fluence antibody response to immunization
with J5 or ovalbumin [29, 56]. Together,
these data suggest a quite limited role – if
any – for prior natural exposure to coliform
mastitis pathogens in protection against
severity.
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3. CONCLUSION
The mechanism of protection against se-
vere coliform mastitis through J5 vaccina-
tion is presently unknown. Data in the
literature support the hypothesis that it may
act by inducing a state of hyper-responsive-
ness within the mammary gland, mediated
by local memory cells. These cells could
contribute to the polarization of the im-
mune response towards a Th1 response re-
sulting in enhanced PMN infiltration upon
intramammary challenge.
ACKNOWLEDGEMENTS
This study has been supported by the Belgian
Ministry of Small Enterprises and Agriculture
(grant S-6014), the Belgian “Fonds voor
Wetenschappelijk Onderzoek” (FWO, grant
31504200) and the Belgian “Instituut tot
aanmoediging van Innovatie door Wetenschap
en Technologie” (post-doctoral research grant
IWT/OZM/000445 to Hilde Dosogne).
REFERENCES
[1] Burvenich C., Dosogne H., Detilleux J., van
Werven T., Is it possible to predict the severity of
acute mastitis during early lactation through
measurement of the activity of circulating
polymorphonuclear cells ? Proceedings Journées
Nationales GTV-INRA, 1999, pp. 43-52.
[2] Butcher E.C., Picker L.J., Lymphocyte homing
and homeostasis, Science 272 (1996) 60-66.
[3] Croitoru K., Bienenstock J., Characteristics and
functions of mucosa-associated lymphoid tis-
sue, in: Ogra P.L., Lamm M.E., McGhee J.R.,
Mestecky J., Strober W., Bienenstock J. (Eds.),
Handbook of Mucosal Immunology, Academic
Press, San Diego, CA, 1994, pp. 414-449.
[4] Cullor J.S., J5 Escherichia coli: a core antigen
vaccine for coliform mastitis, Coliform mastitis
symposium proceedings, Washington State Uni-
versity, College of Veterinary Medicine, 1993,
pp. 30-35.
[5] De Cueninck B.J., Immune-mediated inflamma-
tion in the lumen of the bovine mammary gland,
Int. Arch. Allergy Appl. Immunol. 59 (1979)
394-402.
[6] Dosogne H., Burvenich C., van Werven T., Roets
E., Noordhuizen-Stassen E.N., Goddeeris B., In-
creased surface expression of CD11b receptors
on polymorphonuclear leukocytes is not suffi-
cient to sustain phagocytosis during Escherichia
coli mastitis in early postpartum dairy cows, Vet.
Immunol. Immunopathol. 60 (1997) 47-59.
[7] Dosogne H., Burvenich C., Freeman A.E.,
Kehrli M.E. Jr., Detilleux J.C., Sulon J.,
Beckers J.-F., Hoeben D., Pregnancy-associated
glycoprotein and decreased polymorphonuclear
leukocyte function in early post-partum dairy
cows, Vet. Immunol. Immunopathol. 67 (1999)
47-54.
[8] Frost A.J., Hill A.W., Brooker B.E., The early
pathogenesis of bovine mastitis due to Esche-
richia coli, Proc. R. Soc. Lond. B. Biol. Sci. 209
(1980) 431-439.
[9] Ginaldi L., De Martinis M., D’Ostilio A., Marini
L., Loreto M.F., Quaglino D., The immune sys-
tem in the elderly: III. Innate immunity,
Immunol. Res. 20 (1999) 117-126.
[10] Gonzales R.N., Cullor J.S., Jasper D.E., Farver
T.B., Brushnell R.B., Oliver M.N., Prevention of
clinical coliform mastitis in dairy cows by a mu-
tant Escherichia coli vaccine, Can. J. Vet. Res.
53 (1989) 301-305.
[11] Greisman S.E., Johnston C.A., Failure of anti-
sera to J5 and R595 rough mutants to reduce
endotoxemic lethality, J. Infect. Dis. 157 (1988)
54-64.
[12] Guidry A.J., O’Brien C.N., Current awareness of
bovine mammary gland immunology, Flem. Vet.
J. Suppl. 66 (1997) 341-358.
[13] Heyneman R., Burvenich C., Vercauteren R., In-
teraction between the respiratory burst activity
of neutrophil leukocytes and experimentally in-
duced Escherichia coli mastitis in cows, J. Dairy
Sci. 73 (1990) 985-994.
[14] Hill A.W., Factors influencing the outcome of
Escherichia coli mastitis in the dairy cow, Res.
Vet. Sci. 31 (1981) 107.
[15] Hill A.W., Vaccination of cows with rough Esch-
erichia coli mutants fails to protect against ex-
perimental intramammary bacterial challenge,
Vet. Res. Commun. 15 (1991) 7.
[16] Hoeben D., Monfardini E., Opsomer G.,
Burvenich C., Dosogne H., De Kruif A.,
Beckers J.-F., Chemiluminescence of bovine
polymorphonuclear leukocytes during the
periparturient period and relation with metabolic
markers and bovine pregnancy-associated
glycoprotein, J. Dairy Res. 67 (2000) 249-259.
[17] Hogan J.S., Todhunter D.A., Tomita G.M., Smith
K.L., Schoenberger P.S., Opsonic activity of bo-
vine serum and mammary secretion after Esche-
richia coli J5 vaccination, J. Dairy Sci. 75 (1992)
72-77.
[18] Hogan J.S., Weiss W.P., Todhunter D.A., Smith
K.L., Schoenberger P.S., Efficacy of an Escherichia
coli J5 mastitis vaccine in an experimental chal-
lenge trial, J. Dairy Sci. 75 (1992) 415-422.
10 H. Dosogne et al.
[19] Hogan J.S., Weiss W.P., Smith K.L., Todhunter
D.A., Schoenberger P.S., Effects of an Esche-
richia coli J5 vaccine on mild clinical coliform
mastitis, J. Dairy Sci. 78 (1995) 285-290.
[20] Hogan J.S., Smith K.L., Schoenberger P.,
Roming S., Thompson L., Antibody titer re-
sponses to intramammary immunization with
Escherichia coli J5 bacterin, J. Dairy Sci. 80
(1997) 2398-2402.
[21] Hogan J.S., Bogacz V.L., Aslam M., Smith K.L.,
Efficacy of an Escherichia coli J5 bacterin ad-
ministered to primigravid heifers, J. Dairy Sci.
82 (1999) 939-943.
[22] Kimura K., Goff J.P., Kehrli M.E. Jr., Effects of
the presence of the mammary gland on expres-
sion of neutrophil adhesion molecules and
myeloperoxidase activity in periparturient dairy
cows, J. Dairy Sci. 82 (1999) 2385-2392.
[23] Kremer W.D.J., Noordhuizen-Stassen E.N.,
Grommers F.J., Daemen A.J.J.M., Henricks
P.A.J., Burvenich C., Brand A., Preinfection
chemotactic response of blood polymorphonuclear
leukocytes topredict severityofEscherichiacolibo-
vine mastitis, J. Dairy Sci. 76 (1993) 1568-1574.
[24] Lacey-VanKampen C., Mallard B.A., Effects of
peripartum stress and disease on bovine lympho-
cyte subsets, Vet. Immunol. Immunopathol. 59
(1998) 79-92.
[25] Lammers A., van Vorstenbosch C.J., Erkens
J.H.F., Smith H.E., The major bovine pathogens
have different cell tropisms in cultures of bovine
mammary gland cells, Vet. Microbiol. 80 (2001)
255-265.
[26] Lipman L.J., de Nijs A., Lam T.J., Gaastra W.,
Identification of Escherichia coli strains from
cows with clinical mastitis by serotyping and
DNA polymorphism patterns with REP and
ERIC primers, Vet. Microbiol. 43 (1995) 13-19.
[27] Macatonia S.E., Hsieh C.S., Murphy K.M.,
O’Garra A., Dendritic cells and macrophages are
required for Th1 development of CD4+ T cells
from alpha beta TCR transgenic mice: IL-12
substitution for macrophages to stimulate
IFN-gamma production is IFN-gamma-depend-
ent, Int. Immunol. 5 (1993) 1119-1128.
[28] Mackay C.R., Andrew D.P., Briskin M., Ringler
D.J., Butcher E.C., Phenotype and migration
properties of three major subsets of tissue hom-
ing T cells, Eur. J. Immunol. 26 (1996)
2433-2439.
[29] Mallard B.A., Wagter L.C., Ireland M.J.,
Dekkers J.C.M., Effects of growth hormone, in-
sulin-like growth factor I and cortisol on
periparturient antibody response profiles of
dairy cattle, Vet. Immunol. Immunopathol. 60
(1997) 61-76.
[30] Mallard B.A., Dekkers J.C., Ireland M.J., Leslie
K.E., Sharif S., Lacey Vankampen C., Wagter L.,
Wilkie B.N., Alteration in immune responsive-
ness during the peripartum period and its ramifi-
cation on dairy cow and calf health, J. Dairy Sci.
81 (1998) 585-595.
[31] Morris D.D., Cullor J.S., Whitlock R.H.,
Wickstrom M., Corbeil L.B., Endotoxemia in
neonatal calves given antiserum to a mutant
Escherichia coli (J5), Am. J. Vet. Res. 47 (1986)
2554-2565.
[32] Nickerson S.C., Pankey J.W., Boddie N.T., Dis-
tribution, location, and ultrastructure of plasma
cells in the uninfected, lactating bovine mam-
mary gland, J. Dairy Res. 51 (1984) 209-217.
[33] Park Y.H., Fox L.K., Hamilton M.J., Davis W.C.,
Bovine mononuclear leukocyte subpopulations
in peripheral blood and mammary gland secre-
tions during lactation, J. Dairy Sci. 75 (1992)
998-1006.
[34] Parsons K.R., Howard C.J., Jones B.V., Sopp P.,
Investigation of bovine gut associated lymphoid
tissue (GALT) using monoclonal antibodies
against bovine lymphocytes, Vet. Pathol. 26
(1989) 396-408.
[35] Persson K., Carlsson A., Hambleton C., Guidry
A.J., Immunoglobulins, lysozyme and lactoferrin
in the teat and udder of the dry cow during
endotoxin-induced inflammation, J. Vet. Med. B
39 (1992) 165-174.
[36] Rebelatto M.C., Mead C., HogenEsch H., Lym-
phocyte populations and adhesion molecule ex-
pression in bovine tonsils, Vet. Immunol.
Immunopathol. 73 (2000) 15-29.
[37] Renjifo X., Howard C., Kerkhofs P., Denis M.,
Urbain J., Moser M., Pastoret P.P., Purification
and characterization of bovine dendritic cells
from peripheral blood, Vet. Immunol. Immuno-
pathol. 60 (1997) 77-88.
[38] Rieser C., Ramoner R., Holtl L., Rogatsch H.,
Papesh C., Stenzl A., Bartsch G., Thurnher M.,
Mature dendritic cells induce T-helper
type-1-dominant immune responses in patients
with metastatic renal cell carcinoma, Urol. Int.
63 (2000) 151-159.
[39] Riollet C., Rainard P., Poutrel B., Kinetics of
cells and cytokines during immune-mediated
inflammation in the mammary gland of cows
systemically immunized with Staphylococcus
aureus α-toxin, Inflamm. Res. 49 (2000) 486-
496.
[40] Salmon H., Mammary gland immunology and
neonate protection in pigs, in: Mol J.A., Clegg
R.A. (Eds.), Biology of the mammary gland,
Kluwer Academic / Plenum Publishers, New
York, 2000, pp. 279-286.
[41] Sanchez-Carlo V., Wilson R.A., McDonald J.S.,
Packer R.A., Biochemical and serologic proper-
ties of Escherichia coli isolated from cows with
acute mastitis, Am. J. Vet. Res. 45 (1984)
1771-1774.
[42] Satoshi H., Suzuki-Miki K., Takeyoshi I., Maki
I., Takashi K., Nobuhisa N., Yamamoto-Noriko
T., Meijin T., Effects of paternal lymphocyte
Mechanism of action of J5 vaccine 11
immunization on peripheral Th1/Th2 balance
and TCR Vbeta and Vgamma repertoire usage of
patients with recurrent spontaneous abortions,
Am. J. Reprod. Immunol. 43 (2000) 107-115.
[43] Schuhbauer D.M., Mitchison N.A., Mueller B.,
Interaction within clusters of dendritic cells and
helper T cells during initial Th1/Th2 commit-
ment, Eur. J. Immunol. 30 (2000) 1255-1262.
[44] Shafer-Weaver K.A., Corl C.M., Sordillo L.M.,
Shifts in bovine CD4+ subpopulations increase
T-helper-2 compared with T-helper-1 effector
cells during the postpartum period, J. Dairy Sci.
82 (1999) 1696-1706.
[45] Smith J.L., Hogan J.S., Smith K.L., Efficacy of
intramammary immunization with an Esche-
richia coli J5 bacterin, J. Dairy Sci. 82 (1999)
2582-2588.
[46] Soltys J., Quinn M., Selective recruitment of
T-cell subsets to the udder during Staphylococcal
and Streptococcal mastitis: analysis of lympho-
cyte subsets and adhesion molecule expression,
Infect. Immun. 67 (1999) 6293-6302.
[47] Sordillo L.M., Peel J.E., Effect of interferon-) on
the production of tumor necrosis factor during
acute Escherichia coli mastitis, J. Dairy Sci. 75
(1992) 2119-2125.
[48] Taylor B.C., Dellinger J.D., Cullor J.S., Stott
J.L., Bovine milk lymphocytes display the phe-
notype of memory T cells and are predominantly
CD8+, Cell. Immunol. 156 (1994) 245-253.
[49] Tomita G.M., Nickerson S.C., Owens W.E.,
Wren B., Influence of route of vaccine adminis-
tration against experimental intramammary in-
fection caused by Escherichia coli, J. Dairy Sci.
81 (1998) 2159-2164.
[50] Tomita G.M., Ray C.H., Nickerson S.C., Owens
W.E., Gallo G.F., A comparison of two commer-
cially available Escherichia coli J5 vaccines
against E. coli intramammary challenge, J. Dairy
Sci. 83 (2000) 2276-2281.
[51] Tyler J.W., Cullor J.S., Osburn B.I., Bushnell
R.B., Fenwick B.W., Relationship between sero-
logic recognition of Escherichia coli O111: B4
(J5) and clinical coliform mastitis in cattle, Am.
J. Vet. Res. 49 (1988) 1950-1954.
[52] Tyler J.W., Cullor J.S., Thurmond M.C., Douglas
V.L., Dellinger J.D., Humoral response in neo-
natal calves following immunization with Esch-
erichia coli (strain J5): the effects of adjuvant,
age and colostral passive interference, Vet.
Immunol. Immunopathol. 23 (1989) 333-344.
[53] Tyler J.W., Cullor J.S., Spier S.J., Smith B.P., Im-
munity targeting common core antigens of
Gram-negative bacteria, J. Vet. Int. Med. 4
(1990) 17-25.
[54] Vandeputte-Van Messom G., Burvenich C.,
Roets E., Massart-Leën A.-M., Heyneman R.,
Kremer W.D.J., Brand A., Classification of
newly calved cows into moderate and severe re-
sponders to experimentally induced Escherichia
coli mastitis, J. Dairy Res. 60 (1993) 19-29.
[55] Van Werven T., Noordhuizen-Stassen E.N.,
Daemen A.J.J.M., Schukken Y.H., Brand A.,
Burvenich C., Preinfection in vitro chemotaxis,
phagocytosis, oxidative burst, and expression of
CD11/CD18 receptors and their predictive ca-
pacity on the outcome of mastitis induced in
dairy cows with Escherichia coli, J. Dairy Sci. 80
(1997) 67-74.
[56] Wagter L.C., Mallard B.A., Dekkers J.C.M.,
Leslie K.E., Wilkie B.N., Characterization of
immune responsiveness and disease occurrence
during the peripartum period. J. Dairy Sci. 79
Suppl. 1 (1996) 119 (abstr.).
[57] Washington E.A., Katerelos M., Cahill R.N.P.,
Kimpton W.G., Differences in the tissue-specific
homing of αβand γδ T cells to gut and peripheral
lymph nodes, Int. Immunol. 6 (1994)
1891-1897.
[58] Wegmann T.G., Lin H., Guilbert L., Mosmann
T.R., Bidirectional cytokine interactions in the
maternal-fetal relationship: is successful preg-
nancy a Th2 phenomenon ? Immunol. Today 14
(1993) 353-356.
[59] Young Y.H., Sheep immunology and goat pecu-
liarities. Leukocyte migration, in: Pastoret P.P.,
Griebel P., Bazin H., Govaerts A. (Eds.), Hand-
book of Vertebrate Immunology, Academic
Press, London, 1998, pp. 493-496.
12 H. Dosogne et al.
To access this journal online:
www.edpsciences.org
